Vila J J, Jiménez F J, Irisarri R, Martínez A, Amorena E, Borda F
Servicio de Aparato Digestivo, Hospital de Navarra, Pamplona, Spain.
Rev Esp Enferm Dig. 2007 Mar;99(3):132-7. doi: 10.4321/s1130-01082007000300003.
our aim was to evaluate the accuracy of endosonography (EUS) in our experience, to stage rectal cancer.
we prospectively included all patients with rectal cancer staged in our unit from September 2002 until February 2006 in a database. We selected those patients who had a complete EUS examination and were surgically treated without neoadjuvant therapy. Once we had the results of the histopathological staging (pTN), which was considered the gold standard, we compared the results of the previous EUS staging (uTN) with those of the pTN. We calculated the sensitivity, specificity, positive predictive value, negative predictive value and accuracy for each T stage, and for N staging considered as N positive or negative. We also calculated the global accuracy for T stage. We also calculated the agreement of uTN with pTN staging using the kappa index for N stage, and quadratic weighted kappa index for T stage.
we staged 120 patients with rectal cancer during the mentioned period. Of these, 36 patients met inclusion criteria and were evaluated, 21 women and 15 men. Mean age was 68,53+/-10,15 yo (range: 48-90). Global T stage accuracy was 83%. N stage accuracy was 72%. We obtained a S, E, PPV, NPV and A of 91, 100, 100, 96 and 97% for T1; 82, 88, 75, 91 and 86% for T2; 86, 91, 86, 91 and 89% for T3; and 14, 86, 20, 80 and 72% for N stage respectively. Kappa value for T stage was 0,87 indicating a "very good" agreement between uT and pT according to the kappa index criteria. Kappa value for N stage agreement was 0,005; "poor" according to the same criteria.
in our experience, the diagnostic accuracy of EUS for T and N staging of rectal cancer is 83% and 72% respectively, similar results as previously published. uT staging for rectal cancer shows a "very good" agreement with pT staging.
根据我们的经验,评估内镜超声检查(EUS)对直肠癌进行分期的准确性。
我们前瞻性地将2002年9月至2006年2月在本单位分期的所有直肠癌患者纳入数据库。我们选择了那些接受了完整EUS检查且未接受新辅助治疗而接受手术治疗的患者。一旦获得被视为金标准的组织病理学分期(pTN)结果,我们就将先前EUS分期(uTN)的结果与pTN的结果进行比较。我们计算了每个T分期以及N分期(视为N阳性或阴性)的敏感性、特异性、阳性预测值、阴性预测值和准确性。我们还计算了T分期的总体准确性。我们还使用N分期的kappa指数和T分期的二次加权kappa指数计算了uTN与pTN分期的一致性。
在上述期间,我们对120例直肠癌患者进行了分期。其中,36例患者符合纳入标准并接受了评估,21例女性和15例男性。平均年龄为68.53±10.15岁(范围:48 - 90岁)。T分期的总体准确性为83%。N分期的准确性为72%。T1期的敏感性、特异性、阳性预测值、阴性预测值和准确性分别为91%、100%、100%、96%和97%;T2期分别为82%、88%、75%、91%和86%;T3期分别为86%、91%、86%、91%和89%;N分期分别为14%、86%、20%、80%和72%。根据kappa指数标准,T分期的kappa值为0.87,表明uT与pT之间“非常好”的一致性。N分期一致性的kappa值为0.005;根据相同标准为“差”。
根据我们的经验,EUS对直肠癌T和N分期的诊断准确性分别为83%和72%,与先前发表的结果相似。直肠癌的uT分期与pT分期显示出“非常好”的一致性。